Berman Capital Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $4K | Sell |
476
-10
| -2% | -$84 | ﹤0.01% | 1512 |
|
|
2021
Q2 | $4K | Hold |
486
| – | – | ﹤0.01% | 1427 |
|
|
2021
Q1 | $5K | Sell |
486
-135
| -22% | -$1.39K | ﹤0.01% | 1292 |
|
|
2020
Q4 | $5K | Buy |
621
+175
| +39% | +$1.41K | ﹤0.01% | 1175 |
|
|
2020
Q3 | $4K | Sell |
446
-22
| -5% | -$197 | ﹤0.01% | 1141 |
|
|
2020
Q2 | $5K | Sell |
468
-1,321
| -74% | -$14.1K | ﹤0.01% | 998 |
|
|
2020
Q1 | $15K | Buy |
1,789
+1,427
| +394% | +$12K | ﹤0.01% | 570 |
|
|
2019
Q4 | $3K | Sell |
362
-45
| -11% | -$373 | ﹤0.01% | 1135 |
|
|
2019
Q3 | $2K | Buy |
407
+362
| +804% | +$1.78K | ﹤0.01% | 1232 |
|
|
2019
Q2 | $0 | Sell |
45
-39
| -46% | – | ﹤0.01% | 1571 |
|
|
2019
Q1 | $1K | Sell |
84
-11
| -12% | -$131 | ﹤0.01% | 1266 |
|
|
2018
Q4 | $1K | Buy |
+95
| New | +$1K | ﹤0.01% | 1065 |
|